2024 ´ëÇÑÀÓ»ó¾à¸®ÇÐȸ Ãá°èÇмú´ëȸ : 2024-04-26
±³À°ÀÏÀÚ : 2024-04-26
±³À°Àå¼Ò : ¼Ò³ëº§ Á¦ÁÖ ´ÙÀ̾ƸóµåȦ
±³À°ÁÖÁ¦ : 2024 ´ëÇÑÀÓ»ó¾à¸®ÇÐȸ Ãá°èÇмú´ëȸ
ÁÖÃÖ±â°ü : ´ëÇÑÀÓ»ó¾à¸®ÇÐȸ
´ã´çÀÚ : ¹Ú¼Ò¹Î
¿¬¶ôó : 02-4883-5055
À̸ÞÀÏ : office@kscpt.org
±³À°Á¾·ù : ³»°ú, ¼Ò¾Æû¼Ò³â°ú, ¸¶ÃëÅëÁõÀÇÇаú, º´¸®°ú, °¡Á¤ÀÇÇаú, ¿¹¹æÀÇÇÐ, ¾à¸®ÇÐ
Âü¼®¿¹»óÀÎ : 250¸í
Èñ¸ÁÆòÁ¡ : 6Á¡
Áö¿ª : Á¦ÁÖƯº°ÀÚÄ¡µµ
±³À°½Ã°£ : 6 ½Ã°£ 0ºÐ
¼¼ºÎ¼ö°·á : 180,000¿ø
ºñ°í
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 04¿ù 26ÀÏ ´ÙÀ̾ƸóµåȦ 09:00~10:00 Optimizing treatment for pediatric acute leukemia and development of CAR-T °ÇüÁø(¼¿ï´ëÇб³º´¿ø)
±³À°½Ã°£ 04¿ù 26ÀÏ ´ÙÀ̾ƸóµåȦ 10:30~11:00 ±Û·Î¹ú Á¦¾à.¹ÙÀÌ¿À ½Å¾à°³¹ß µ¿Çâ-¼¼Æ÷ À¯ÀüÂ÷ Ä¡·áÁ¦¸¦ Áß½ÉÀ¸·Î ¹ÚÈ¿Áø(±¹°¡½Å¾à°³¹ß»ç¾÷´Ü)
±³À°½Ã°£ 04¿ù 26ÀÏ ´ÙÀ̾ƸóµåȦ 11:00~11:30 CAR-T Ä¡·áÁ¦ÀÇ ±Û·Î¹ú °³¹ßµ¿Çâ ¹× Àü·« ±è°Ç¼ö(Å¥·Î¼¿)
±³À°½Ã°£ 04¿ù 26ÀÏ ´ÙÀ̾ƸóµåȦ 11:30~12:00 Genetically Engineered Mesenchymal Stem Cells for the Therapy of Glioblastoma ¼ÇØ¿µ(¾ÆÁÖ´ëÇб³)
±³À°½Ã°£ 04¿ù 26ÀÏ ´ÙÀ̾ƸóµåȦ 13:30~14:00 ¼¼Æ÷À¯ÀüÀÚ Ä¡·áÁ¦ ºñÀÓ»ó °³¹ß ¹× °í·Á»çÇ× °¼®¸ð(ÁÖ¹ÙÀÌ¿ÀÅ彺ÅØ)
±³À°½Ã°£ 04¿ù 26ÀÏ ´ÙÀ̾ƸóµåȦ 14:00~14:30 ¼¼Æ÷Ä¡·áÁ¦ÀÇ È¿´É ºÐ¼®¹ý: FACS¿Í ´ÜÀϼ¼Æ÷Àü»çü ºÐ¼® °æÇèÀ» Áß½ÉÀ¸·Î ±èÇöÁ¦(¼¿ï´ëÇб³)
±³À°½Ã°£ 04¿ù 26ÀÏ ´ÙÀ̾ƸóµåȦ 14:30~15:00 Strategies for Cell Therapy Development: Optimizing Dosage ±èº´¿í(¼¿ï´ëÇб³º´¿ø)
±³À°½Ã°£ 04¿ù 26ÀÏ ´ÙÀ̾ƸóµåȦ 15:30~15:50 Support for Clinical Research of Regenerative Medicine Advanced Therapy in Korea MinYoung Kim(Regenerative Medicine Acceleration Foundation)
±³À°½Ã°£ 04¿ù 26ÀÏ ´ÙÀ̾ƸóµåȦ 15:50~16:10 Challenges in the practical application of cell-processed products derived from iPS/ES cells Satoshi Yasuda(National Institute of Health Sciences)
±³À°½Ã°£ 04¿ù 26ÀÏ ´ÙÀ̾ƸóµåȦ 16:10~16:30 Recent Advances in CAR-T Cell Therapy in Hematologic Malignancies Nahoko Hosono(University of Fukui)
±³À°½Ã°£ 04¿ù 26ÀÏ ´ÙÀ̾ƸóµåȦ 16:50~17:10 Clinical trial protocol for porcine islet xenotransplantation in South Korea Byung-Joon Kim(Gil International Healthcare Center)
±³À°½Ã°£ 04¿ù 26ÀÏ ´ÙÀ̾ƸóµåȦ 17:10~17:30 Bioanalysis of recombinant viral vector by qPCR and digital PCR for biodistribution Yoichi Tanaka(National Institute of Health Sciences)
±³À°½Ã°£ 04¿ù 26ÀÏ ´ÙÀ̾ƸóµåȦ 17:30~17:50 PKPD modeling of cancer immunotherapy targeting IL-2 receptor Dongwoo Chae(Yonsei University College of Medicine)